It is a pharma private limited company based in Greater Noida, Uttar Pradesh, India, established in 2016.
2016 | Greater Noida, Uttar Pradesh, India | ActiveFloare & Zuvaka Global Pharma Private Limited, a active private limited company, was established on 16 August 2016 in Greater Noida, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100UP2016PTC085665. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Employing 7 professional, Its leadership includes Prabhat Kumar Awasthi (Director), Priyanshu Dixit (Director). Past directors included Prabhat Kumar Awasthi, Brij Bhushan Bakshi, Vibhu Dixit. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 174, Udyog Kendra Extn -Ii, Ecotech – 3, Greater Noida, Uttar Pradesh, 201306.
U24100UP2016PTC085665
085665
16 August 2016
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Floare & Zuvaka Global Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhat Kumar Awasthi | Director | 13 Jul 2023 | Current |
| Priyanshu Dixit | Director | 22 Dec 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Nov 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Oct 2017 | Past |
| Pramod Abcsdd | Director | 14 Jul 2023 | Past |
| Pramod Abcsdd | Director | 20 Nov 2020 | Past |
| Pramod Abcsdd | Director | 20 Nov 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Floare & Zuvaka Global Pharma Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 252.74% increase. The company also saw a substantial fall in profitability, with a 73.06% decrease in profit. The company's net worth observed a substantial decline by a decrease of 336.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Floare & Zuvaka Global Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Aug 2022 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Floare & Zuvaka Global Pharma has a workforce of 7 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Floare & Zuvaka Global Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Floare & Zuvaka Global Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Floare & Zuvaka Global Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Floare & Zuvaka Global Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
The activity Prabhat Kumar Awasthi was appointed as a Director was appointed as a Director on 13 Jul 2023 & has been associated with this company since 2 years 4 months . was completed.
The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 100678917 was registered on 18 Aug 2022. was completed.
Priyanshu Dixit was appointed as a Director was appointed as a Director on 22 Dec 2018 & has been associated with this company since 6 years 11 months . was recorded as a recent event.
Progress on Floare & Zuvaka Global Pharma Private Limited was registered on 16 Aug 2016 with Roc Kanpur & aged 9 years 3 months as per MCA records. was documented.
The CIN of Floare & Zuvaka Global Pharma Private Limited is U24100UP2016PTC085665.
Floare & Zuvaka Global Pharma Private Limited is headquartered at 174, Udyog Kendra Extn -Ii, Ecotech – 3, Greater Noida, Uttar Pradesh, 201306.
Floare & Zuvaka Global Pharma Private Limited was incorporated on 16 August 2016.
The current directors of Floare & Zuvaka Global Pharma Private Limited are
The primary industry of Floare & Zuvaka Global Pharma Private Limited is Manufacturing.
Floare & Zuvaka Global Pharma Private Limited is unlisted.
The authorized capital of Floare & Zuvaka Global Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Floare & Zuvaka Global Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX